Assignee
NUMAB AG
CH·1 granted patent·4 pending applications·3 citations·filing 2014–2015
Top patents by PatentIndex Score
5 records- 0174US10077312B2CD3 and IL-23 receptor binding bispecific constructs and their use in the treatment of various diseasesNUMAB AG·Filed 2014·Granted Sep 18, 2018·3 cites·18 claims
- 0243US2016090416A1Novel antibodiesNUMAB AG·Filed 2014·Application pending·0 cites
- 0342US2015329637A1Depletion of il23r expressing cells in the treatment of various diseasesNUMAB AG·Filed 2015·Application pending·0 cites
- 0441US2017073415A1Novel multispecific molecules and novel treatment methods based on such multispecific moleculesNUMAB AG·Filed 2014·Application pending·0 cites
- 0540US2016368987A1Bispecific constructs and their use in the treatment of various diseasesNUMAB AG·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →